Our previous study reported a melanin nanoprobe targeting PSMA performed successfully for PET/MR/PA imaging and combined therapy in PSMA-positive mouse model, which displayed enhanced permeability and retention (EPR) effects and targeting ability, long-acting properties at the tumor region [16,23]. Here, FOLH1 is linked to neoplasm.